Veterinary Medicines

CRISAX 17 MG/100 MG/40 MG COMPRIMES POUR CHIENS ET CHATS

Authorised
  • Camphor monobromide
  • Phenobarbital
  • Potassium bromide
Download as PDF

Product identification

Medicine name:
CRISAX 17 MG/100 MG/40 MG COMPRIMES POUR CHIENS ET CHATS
Active substance:
  • Camphor monobromide
  • Phenobarbital
  • Potassium bromide
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Camphor monobromide
    40.00
    milligram(s)
    /
    1.00
    Tablet
  • Phenobarbital
    17.00
    milligram(s)
    /
    1.00
    Tablet
  • Potassium bromide
    100.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Domes Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Europeenne De Pharmacotechnie Europhartech
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/5726040 2/1992
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 13/10/2023
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 10/10/2024
Download
How useful was this page?:
Average: 1 (3 votes)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."